Výsledky vyhledávání - "Cristina Foli"

Akademický článek

Eficácia e Segurança de Regorafenibe em Pacientes com Características de Bom Prognóstico no Tratamento do Câncer Colorretal Metastático: Análise de Subgrupo do Estudo CORRECT

Autor: Rodrigo Resende Palhares, Glauco do Canto Britto, Yun Su, Marie-Aude Le Berre, Ricardo Saad Henriques, Fabricio Volpato Navachi, Daniela Cristina Foli Pereira, Helene Ostojic, Graziella Agostini Azevedo, Eric Van Cutsem

Publikováno v: Revista Brasileira de Cancerologia, Vol 68, Iss 4 (2022)

Introdução: O câncer colorretal (CCR) é o segundo mais incidente e, quando metastático, apresenta taxa de sobrevida de 14% em cinco anos. Regorafenibe é um inibidor de tirosina-quinase (ITQ) aprovado para CCR metastático (CCRm) com aumento com

Externí odkaz: https://doaj.org/article/9a28d27aaf5b4bf6b0631427abbfb0f2

Zobrazit plný text záznamu

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)

Autor: Luca Lanino, Prassede Salutari, Alessandra Perego, Bruno Fattizzo, Marta Riva, Marta Ubezio, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Maria Teresa Voso, Anna Maria Pelizzari, Antonella Poloni, Isabella Capodanno, Chiara Elena, Claudio Fozza, Fabrizio Pane, Massimo Breccia, Marco De Gobbi, Francesco Di Bassiano, Daniela Barraco, Elena Crisà, Dario Ferrero, Chiara Frairia, Antonella Vaccarino, Davide Griguolo, Stefania Paolini, Martina Quintini, Mariarosaria Sessa, Mauro Turrini, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Cristina Foli, Alfredo Molteni, Ubaldo Occhini, Giulia Rivoli, Carmine Selleri, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Alessandro Rambaldi, Ilaria Tanasi, Patrizia Tosi, Ilaria Naldi, Valeria Santini, Matteo G. Della Porta

Publikováno v: Blood. 140:6945-6948

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5e3d8b261e1bc8753449a28450b621a7
https://doi.org/10.1182/blood-2022-164559

Zobrazit plný text záznamu

Eficacia y Seguridad de Regorafenib en Pacientes con Características de Buen Pronóstico en Tratamiento del Cáncer Colorrectal Metastásico: Análisis de Subgrupo del Estudio CORRECT

Autor: Palhares, Rodrigo Resende, Britto, Glauco do Canto, Su, Yun, Le Berre, Marie-Aude, Henriques, Ricardo Saad, Navachi, Fabricio Volpato, Pereira, Daniela Cristina Foli, Ostojic, Helene, Azevedo, Graziella Agostini, Van Cutsem, Eric

Publikováno v: Revista Brasileira de Cancerologia; Vol. 68 No. 4 (2022): Oct./Nov./Dec.; e-162727
Revista Brasileira de Cancerologia; Vol. 68 Núm. 4 (2022): oct./nov./dic.; e-162727
Revista Brasileira de Cancerologia; v. 68 n. 4 (2022): out./nov./dez.; e-162727
Revista Brasileira de Cancerologia
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA

Introduction: Colorectal cancer (CRC) is the second most common and when metastatic, it has a five-year survival rate of 14%. Regorafenib is an approved TKI for metastatic colorectal cancer (mCRC) with a proven increase in overall survival (OS). Obje

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3056::3f19fddcbbb6e4ed077dc0f6341992a0
https://rbc.inca.gov.br/index.php/revista/article/view/2727

Zobrazit plný text záznamu

Long-term follow-up of myelodysplastic syndrome patients with moderate/severe anaemia receiving human recombinant erythropoietin + 13-cis-retinoic acid and dihydroxylated vitamin D3: independent positive impact of erythroid response on survival

Autor: Elena Crisà, Roberto Passera, Kimberly B. Garvey, Antonella Darbesio, Dario Ferrero, Mario Boccadoro, Cristina Foli

Publikováno v: British Journal of Haematology. 158:99-107

Summary We previously reported a 60% erythroid response rate with recombinant erythropoietin + 13-cis retinoic acid + dihydroxylated vitamin D3 in 63 elderly myelodysplastic patients (median age 75 years) with unfavourable features for response to er

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a061b75a0d8e19c97baecb82b80cbf
https://doi.org/10.1111/j.1365-2141.2012.09125.x

Zobrazit plný text záznamu

Lupus Anticoagulant: Performance of a New, Fully Automated Commercial Screening and Confirmation Assay

Autor: Cecilia Rus, Cecilia Agnes, Cristina Foli, Barbara Montaruli, Maddalena Saitta, Mario Bazzan, Antonella Vaccarino

Publikováno v: Clinical Chemistry. 51:1031-1033

Lupus anticoagulants (LAs) are acquired circulating anticoagulants that interfere with phospholipid (PL)-dependent coagulation tests and are frequently associated with thromboembolic disorders and obstetric complications. Detection of LAs is of major

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43f5ae40bb1f8fec0bd0661a773cf682
https://doi.org/10.1373/clinchem.2004.042028

Zobrazit plný text záznamu

Long Term Follow-up of a Population of Low-Intermediate Risk Myelodisplastyc Syndrome Patients Treated with a Combination of Recombinant Erythropoietin, 13-Cis-Retinoic Acid and Dihydroxylated Vitamin D3 Confirms the Positive Role of Erythroid Response on Survival

Autor: Mario Boccadoro, Dario Ferrero, Elena Crisà, Antonella Darbesio, Cristina Foli, Valentina Giai

Publikováno v: Blood. 116:4968-4968

Abstract 4968 In our previous paper (Ferrero et al, BJH 2009) we reported the treatment of 63 MDS patients (median age 75, 16 RAEB1, 47 non RAEB) with a combination of human recombinant erythropoietin (alfa or beta epoetin, 30–80000 U/ week, median

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4b577bf936e0bd5b9030d90c27f775e2
https://doi.org/10.1182/blood.v116.21.4968.4968

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání